Previous Chapter Chapter 55: US Markets for Orthopedic Biomaterials Next Chapter

  • Citations
  • Add to My List
  • Text Size

US Markets for Orthopedic Biomaterials
US markets for orthopedic biomaterials
Millennium Research Group, A Decision Resources, Inc. Company

Reaching a value of over $1.7 billion in 2005, the US market for orthopedic biomaterials comprises the following segments:

  • Bone graft substitutes (BGS)
  • Spinal machined bone
  • Osteoarticular allografts
  • Hyaluronic acid (HA) viscosupplementation
  • Emerging growth factor (GF) technologies
  • Platelet concentration systems (PCS)
  • Autologous chondrocyte implantation (ACI)

Exhibit 10.1 Orthopedic Biomaterials Market, US (US$M), 2004–2010
Source: Millennium Research Group.

Demand for orthopedic biomaterials, in large part, is being driven by the aging yet active population that requires greater care and maintenance of their tissues and joints. Degenerative disc disease and osteoarthritis, two conditions frequently associated with aging, are often treated with spinal fusion, which in many cases involves the use of BGS or machined bone as well as HA viscosupplementation ...

Looks like you do not have access to this content.


Don’t know how to login?

Click here for free trial login.

Back to Top

Copy and paste the following HTML into your website